Nektar Therapeutics SEC filings NKTR
Nektar Therapeutics has 1,000 filings in SEC EDGAR's recent list, going back to Aug 5, 2015. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Oct 20, 2026 | — |
| S-8 | Employee stock plan registration | Aug 14, 2026 | — |
| 424B5 | Prospectus supplement | May 8, 2026 | — |
| 424B5 | Prospectus supplement | Apr 23, 2026 | — |
| 424B5 | Prospectus supplement | Apr 20, 2026 | — |
| 424B5 | Prospectus supplement | Feb 13, 2026 | — |
| 424B5 | Prospectus supplement | Feb 10, 2026 | — |
| S-8 | Employee stock plan registration | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| S-3ASR | Automatic shelf registration | Nov 12, 2025 | — |
| S-8 | Employee stock plan registration | Aug 8, 2025 | — |
| 424B5 | Prospectus supplement | Jul 1, 2025 | — |
| 424B5 | Prospectus supplement | Jun 30, 2025 | — |
| S-3 | Shelf registration | Mar 28, 2025 | — |
| S-8 | Employee stock plan registration | Mar 14, 2025 | — |
| 424B3 | Prospectus | Jun 5, 2024 | — |
| S-3 | Shelf registration | May 28, 2024 | — |
| S-8 | Employee stock plan registration | Aug 14, 2023 | — |
| S-8 | Employee stock plan registration | Aug 5, 2022 | — |
| S-8 | Employee stock plan registration | Aug 18, 2021 | — |
| S-3ASR | Automatic shelf registration | Mar 12, 2021 | — |
| S-8 | Employee stock plan registration | Aug 7, 2020 | — |
| S-8 | Employee stock plan registration | Jun 29, 2018 | — |
| S-8 | Employee stock plan registration | Jun 15, 2017 | — |
| 424B5 | Prospectus supplement | Oct 19, 2016 | — |
| 424B5 | Prospectus supplement | Oct 17, 2016 | — |
| S-8 | Employee stock plan registration | Aug 6, 2015 | — |
Showing 27 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NKTR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 906709
- Former names
- INHALE THERAPEUTIC SYSTEMS INC (until Jan 10, 2003); INHALE THERAPEUTIC SYSTEMS (until May 14, 1998)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.